Mean level of HbA1c for the entire sample ( regardless of treatment arm ) did not change between baseline and 18 month follow-up ( p = 0.09 ) , but rates of severe hypoglycaemia , diabetes related hospital attendance , levels of anxiety , depression , the burden of living with diabetes , quality of life and treatment satisfaction all significantly improved .
